Pii to double aseptic GMP capacity

摘要

Pharmaceutics International, Inc (Pii), a US-headquartered contract development and manufacturing organisation specialising in difficult to formulate compounds, will more than double its sterile GMP manufacturing capacity with a new 24,000ft2 cGMP aseptic fill/finish manufacturing plant currently under construction in Hunt Valley, Maryland. Pii says the expansion is focused on meeting current projects with near-term commercial manufacturing needs and on meeting demand for larger batch sizes Targeted for completion in Q4, fill/finish suites will include automated vial and svringe filling.